Amplio Pharma BV

Private

AmsterdamHealthcare & Life Scienceshttps://www.amplio-pharma.com/

Last Round

Seed

Feb 17, 2026

Est. Valuation

$9.5M

Total Funding Raised

$1.4M

Company Overview

Amplio Pharma BV is a pharmaceutical company developing improved versions of existing drugs intended to treat autoimmune diseases like rheumatoid arthritis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

drug reformulationsupergenericspharmacokinetics enhancerPK enhancermethotrexate enhancementautoimmune diseasesrheumatoid arthritisclinical-stage pharmadrug enhancementdrug developmentimmune-mediated inflammatory diseasesIMIDsdrug candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplio Pharma BV Comps

Public and private peers based on sector, stage, and business model.

Amplio Pharma BV comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amplio Pharma BV Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Feb 17, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Karin von Wachenfeldt

Interim CEO

Executive Team

Marguérite Mensonides Harsema

CEO and Co-founder of BV, Head of Business Development, COO and Co-founder of AB

Founding Team

Amplio Pharma BV Investors

Notable investors and investment history

Amplio Pharma BV investors
Investor	Rounds
ROM InWest	Seed
Innovatiefonds Noord-Holland	Seed
Libertatis Ergo Holding	Seed

View all Investors

Amplio Pharma BV Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Amplio Pharma BV Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amplio Pharma BV's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam

Employee Range8

Year Founded2023

Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.